STERIS plc (NYSE:STE) Shares Sold by Kohmann Bosshard Financial Services LLC

Kohmann Bosshard Financial Services LLC decreased its holdings in shares of STERIS plc (NYSE:STE) by 26.2% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,454 shares of the medical equipment provider’s stock after selling 516 shares during the quarter. Kohmann Bosshard Financial Services LLC’s holdings in STERIS were worth $299,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in STE. Ashton Thomas Securities LLC acquired a new stake in STERIS during the third quarter worth $25,000. Human Investing LLC acquired a new stake in STERIS during the fourth quarter worth $31,000. Anfield Capital Management LLC boosted its position in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 91 shares during the period. Central Pacific Bank Trust Division boosted its position in shares of STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC boosted its position in shares of STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 137 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. JMP Securities restated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler raised their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Finally, Stephens restated an “overweight” rating and set a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $258.75.

STERIS Trading Down 0.4 %

NYSE:STE opened at $219.23 on Friday. The firm has a market cap of $21.54 billion, a PE ratio of 46.54 and a beta of 0.84. The stock has a fifty day moving average price of $214.99 and a 200 day moving average price of $223.01. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Sell-side analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be issued a $0.57 dividend. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.04%. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.